News

Home > News & Events > Israeli Startup, Kaiser Study Uses AI to Identify Patients at High Risk for Colorectal Cancer

Israeli Startup, Kaiser Study Uses AI to Identify Patients at High Risk for Colorectal Cancer

Israeli Startup, Kaiser Study Uses AI to Identify Patients at High Risk for Colorectal Cancer
Date

October 5, 2017

by Stacy Lawrence, Staff Writer

Volume 21, No. 193

 

Electronic health records (EHRs) haven’t exactly been the boon to population health that many had initially anticipated. But startup Medial Earlysign, based in Kfar Malal, Israel, is working to change that. It is using machine learning on millions of EHR records to find and apply patterns in existing patient data to notify health care systems and providers of the highest risk patients for further follow-up.

 

Click here to download the full article PDF.